| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GHR CXCR5 GABRE PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C GLRA2 GLRB FPR3 OR4K1 MFSD6 OR4F4 NPSR1 MC4R GLRA3 HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB TMEM63A | 1.46e-16 | 1353 | 64 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 1.98e-13 | 884 | 64 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 3.51e-09 | 41 | 64 | 6 | GO:0008227 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.25e-07 | 133 | 64 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.19e-07 | 140 | 64 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 6.24e-07 | 6 | 64 | 3 | GO:0004936 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 6.24e-07 | 6 | 64 | 3 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 6.24e-07 | 6 | 64 | 3 | GO:0016934 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.04e-07 | 100 | 64 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 1.74e-06 | 8 | 64 | 3 | GO:0005237 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A1 SLC7A8 GABRE SLC8A1 SLC46A3 SLC37A3 AQP11 GLRA2 SLC22A2 GLRB TMEM38A GLRA3 HRH1 MFSD2B LMBRD1 TMEM63A | 2.11e-06 | 1289 | 64 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A1 SLC7A8 GABRE SLC8A1 SLC46A3 SLC37A3 AQP11 GLRA2 SLC22A2 GLRB TMEM38A GLRA3 HRH1 MFSD2B TMEM63A | 3.53e-06 | 1180 | 64 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 3.71e-06 | 10 | 64 | 3 | GO:0004935 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A1 GABRE SLC8A1 SLC46A3 SLC37A3 AQP11 GLRA2 GLRB TMEM38A GLRA3 HRH1 TMEM63A | 4.39e-06 | 758 | 64 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | glycine-gated chloride ion channel activity | 1.01e-05 | 2 | 64 | 2 | GO:0022852 | |
| GeneOntologyMolecularFunction | glycine binding | 1.11e-05 | 14 | 64 | 3 | GO:0016594 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.80e-05 | 171 | 64 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.98e-05 | 50 | 64 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | hormone binding | 1.98e-05 | 103 | 64 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 3.03e-05 | 3 | 64 | 2 | GO:0004938 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.55e-05 | 193 | 64 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.98e-05 | 197 | 64 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.03e-05 | 125 | 64 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.61e-05 | 65 | 64 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.61e-05 | 65 | 64 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.09e-04 | 77 | 64 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.23e-04 | 151 | 64 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | epinephrine binding | 1.50e-04 | 6 | 64 | 2 | GO:0051379 | |
| GeneOntologyMolecularFunction | histamine receptor activity | 1.50e-04 | 6 | 64 | 2 | GO:0004969 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.67e-04 | 86 | 64 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A1 GABRE SLC8A1 SLC46A3 GLRA2 GLRB TMEM38A GLRA3 HRH1 TMEM63A | 2.00e-04 | 793 | 64 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.34e-04 | 103 | 64 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.54e-04 | 43 | 64 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 3.59e-04 | 9 | 64 | 2 | GO:0005275 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.68e-04 | 296 | 64 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 4.47e-04 | 431 | 64 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 6.54e-04 | 12 | 64 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 6.56e-04 | 53 | 64 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.94e-04 | 334 | 64 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 7.31e-04 | 55 | 64 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | catecholamine binding | 7.71e-04 | 13 | 64 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 8.12e-04 | 57 | 64 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 8.15e-04 | 477 | 64 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 9.43e-04 | 60 | 64 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | channel activity | 1.42e-03 | 525 | 64 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.44e-03 | 526 | 64 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.66e-03 | 73 | 64 | 3 | GO:0016597 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.80e-03 | 75 | 64 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.94e-03 | 165 | 64 | 4 | GO:0140375 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.24e-03 | 22 | 64 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | amide binding | 2.70e-03 | 299 | 64 | 5 | GO:0033218 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 3.37e-03 | 27 | 64 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.47e-03 | 459 | 64 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | peptide binding | 3.51e-03 | 318 | 64 | 5 | GO:0042277 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 4.43e-03 | 31 | 64 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.67e-03 | 105 | 64 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 5.31e-03 | 34 | 64 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 6.27e-03 | 37 | 64 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.90e-03 | 138 | 64 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | symporter activity | 1.24e-02 | 150 | 64 | 3 | GO:0015293 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C GLRA2 GLRB FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 MFSD2B OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 2.34e-13 | 1395 | 60 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | SLC6A1 SLC7A8 SLC8A1 ADRA1D ADRA2B ADRA2C SLC22A2 HRH1 HRH2 EDNRB | 5.26e-08 | 344 | 60 | 10 | GO:0003018 |
| GeneOntologyBiologicalProcess | vasoconstriction | 5.99e-08 | 121 | 60 | 7 | GO:0042310 | |
| GeneOntologyBiologicalProcess | circulatory system process | SLC6A1 SLC7A8 SLC8A1 ADRA1D ADRA2B ADRA2C SLC22A2 TMEM38A HRH1 HRH2 BDKRB1 EDNRB | 1.08e-06 | 733 | 60 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 1.94e-06 | 202 | 60 | 7 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 1.94e-06 | 202 | 60 | 7 | GO:0035296 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 2.00e-06 | 203 | 60 | 7 | GO:0035150 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.52e-06 | 134 | 60 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 4.47e-06 | 326 | 60 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A1 GABRE SLC8A1 SLC46A3 SLC37A3 GLRA2 GLRB NPSR1 TMEM38A GLRA3 HRH1 BDKRB1 EDNRB | 5.62e-06 | 1017 | 60 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A1 GABRE SLC8A1 SLC46A3 AQP11 GLRA2 SLC22A2 GLRB NPSR1 TMEM38A GLRA3 HRH1 BDKRB1 EDNRB TMEM63A | 6.43e-06 | 1374 | 60 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 9.70e-06 | 98 | 60 | 5 | GO:0019229 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.38e-05 | 180 | 60 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A1 GABRE SLC8A1 SLC46A3 GLRA2 GLRB NPSR1 TMEM38A GLRA3 HRH1 BDKRB1 EDNRB TMEM63A | 1.51e-05 | 1115 | 60 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | epinephrine transport | 1.55e-05 | 17 | 60 | 3 | GO:0048241 | |
| GeneOntologyBiologicalProcess | positive regulation of vasoconstriction | 1.84e-05 | 54 | 60 | 4 | GO:0045907 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.86e-05 | 112 | 60 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 3.04e-05 | 124 | 60 | 5 | GO:0007218 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.54e-05 | 128 | 60 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 4.25e-05 | 133 | 60 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 4.71e-05 | 224 | 60 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | receptor transactivation | 4.97e-05 | 4 | 60 | 2 | GO:0035624 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 5.14e-05 | 25 | 60 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 6.94e-05 | 618 | 60 | 9 | GO:0090066 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.27e-05 | 153 | 60 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle contraction | 9.93e-05 | 31 | 60 | 3 | GO:0014829 | |
| GeneOntologyBiologicalProcess | blood circulation | 9.96e-05 | 648 | 60 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 1.43e-04 | 35 | 60 | 3 | GO:0071875 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 1.77e-04 | 547 | 60 | 8 | GO:0007606 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 1.84e-04 | 38 | 60 | 3 | GO:0015874 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 1.91e-04 | 98 | 60 | 4 | GO:0051279 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.91e-04 | 183 | 60 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 2.50e-04 | 432 | 60 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | regulation of system process | 2.54e-04 | 734 | 60 | 9 | GO:0044057 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 3.69e-04 | 10 | 60 | 2 | GO:0032811 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 3.90e-04 | 465 | 60 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | negative regulation of norepinephrine secretion | 4.50e-04 | 11 | 60 | 2 | GO:0010700 | |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 4.50e-04 | 11 | 60 | 2 | GO:0014060 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 4.50e-04 | 11 | 60 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 5.01e-04 | 485 | 60 | 7 | GO:0050907 | |
| GeneOntologyBiologicalProcess | righting reflex | 5.39e-04 | 12 | 60 | 2 | GO:0060013 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 5.39e-04 | 12 | 60 | 2 | GO:0070472 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.09e-04 | 133 | 60 | 4 | GO:0007200 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 6.36e-04 | 13 | 60 | 2 | GO:0048242 | |
| GeneOntologyBiologicalProcess | ether lipid biosynthetic process | 6.36e-04 | 13 | 60 | 2 | GO:0008611 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 6.36e-04 | 13 | 60 | 2 | GO:0070471 | |
| GeneOntologyBiologicalProcess | glycerol ether biosynthetic process | 6.36e-04 | 13 | 60 | 2 | GO:0046504 | |
| GeneOntologyBiologicalProcess | amine transport | 6.81e-04 | 137 | 60 | 4 | GO:0015837 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 7.40e-04 | 14 | 60 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | ether biosynthetic process | 7.40e-04 | 14 | 60 | 2 | GO:1901503 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 7.47e-04 | 61 | 60 | 3 | GO:0007187 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 7.91e-04 | 524 | 60 | 7 | GO:0009593 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.42e-04 | 145 | 60 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 8.64e-04 | 146 | 60 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 8.86e-04 | 147 | 60 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.32e-04 | 149 | 60 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 9.56e-04 | 392 | 60 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | regulation of eating behavior | 9.73e-04 | 16 | 60 | 2 | GO:1903998 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.03e-03 | 153 | 60 | 4 | GO:0051208 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.06e-03 | 400 | 60 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.45e-03 | 286 | 60 | 5 | GO:0007188 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.45e-03 | 582 | 60 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A1 SLC8A1 SLC46A3 NPSR1 TMEM38A HRH1 BDKRB1 EDNRB TMEM63A | 1.51e-03 | 942 | 60 | 9 | GO:0098655 |
| GeneOntologyBiologicalProcess | response to caffeine | 1.69e-03 | 21 | 60 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A1 SLC8A1 SLC46A3 SLC22A2 NPSR1 TMEM38A HRH1 BDKRB1 EDNRB TMEM63A | 1.72e-03 | 1157 | 60 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.85e-03 | 22 | 60 | 2 | GO:0010881 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.87e-03 | 180 | 60 | 4 | GO:0060078 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 2.02e-03 | 23 | 60 | 2 | GO:0033604 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.02e-03 | 23 | 60 | 2 | GO:0098664 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 2.09e-03 | 87 | 60 | 3 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 2.15e-03 | 88 | 60 | 3 | GO:0010232 | |
| GeneOntologyBiologicalProcess | glycerol ether metabolic process | 2.20e-03 | 24 | 60 | 2 | GO:0006662 | |
| GeneOntologyBiologicalProcess | ether lipid metabolic process | 2.20e-03 | 24 | 60 | 2 | GO:0046485 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2.32e-03 | 191 | 60 | 4 | GO:0007189 | |
| GeneOntologyBiologicalProcess | cellular response to ethanol | 2.39e-03 | 25 | 60 | 2 | GO:0071361 | |
| GeneOntologyBiologicalProcess | activation of protein kinase B activity | 2.39e-03 | 25 | 60 | 2 | GO:0032148 | |
| GeneOntologyBiologicalProcess | amino acid transport | 2.50e-03 | 195 | 60 | 4 | GO:0006865 | |
| GeneOntologyBiologicalProcess | secretion | SLC6A1 ADRA2B ADRA2C SLC22A2 NPSR1 MC4R HRH2 C1QTNF3 EDNRB TMEM63A | 2.56e-03 | 1221 | 60 | 10 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 2.59e-03 | 26 | 60 | 2 | GO:0014061 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 2.76e-03 | 96 | 60 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 2.79e-03 | 27 | 60 | 2 | GO:0098719 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 2.84e-03 | 202 | 60 | 4 | GO:0006937 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 3.00e-03 | 28 | 60 | 2 | GO:0048243 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 3.00e-03 | 28 | 60 | 2 | GO:0071294 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 3.00e-03 | 28 | 60 | 2 | GO:0010882 | |
| GeneOntologyCellularComponent | glycine-gated chloride channel complex | 9.23e-06 | 2 | 64 | 2 | GO:0016935 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.79e-05 | 57 | 64 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SGPP1 TEX261 SLC37A3 REEP1 CHPT1 AQP11 TMEM38A PEDS1 CYP4X1 XK BFAR LMBRD1 TMEM86A GRAMD4 | 2.89e-05 | 1293 | 64 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | glycinergic synapse | 3.01e-05 | 20 | 64 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SGPP1 TEX261 SLC37A3 REEP1 CHPT1 AQP11 TMEM38A PEDS1 CYP4X1 XK BFAR LMBRD1 TMEM86A GRAMD4 | 3.04e-05 | 1299 | 64 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SGPP1 TEX261 SLC37A3 REEP1 CHPT1 AQP11 TMEM38A PEDS1 CYP4X1 XK BFAR LMBRD1 TMEM86A GRAMD4 | 3.85e-05 | 1327 | 64 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | synaptic membrane | 6.74e-05 | 583 | 64 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.34e-04 | 405 | 64 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | lysosomal membrane | 5.16e-04 | 462 | 64 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 5.16e-04 | 462 | 64 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | vacuolar membrane | 8.91e-04 | 507 | 64 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SLC6A1 GHR GABRE SLC8A1 ADRA2C AQP11 GLRB GLRA3 HRH1 HRH2 DENND1A | 1.15e-03 | 1228 | 64 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.61e-03 | 164 | 64 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | dendrite | 4.52e-03 | 858 | 64 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.58e-03 | 860 | 64 | 8 | GO:0097447 | |
| Domain | GPCR_Rhodpsn_7TM | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 3.17e-15 | 670 | 64 | 21 | IPR017452 |
| Domain | 7tm_1 | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 3.89e-15 | 677 | 64 | 21 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 4.91e-15 | 685 | 64 | 21 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 5.83e-15 | 691 | 64 | 21 | PS50262 |
| Domain | GPCR_Rhodpsn | CXCR5 PROKR1 OR4F5 OR52R1 ADRA1D ADRA2B ADRA2C FPR3 OR4K1 OR4F4 NPSR1 MC4R HRH1 OR4F17 HRH2 TAAR5 OR56A1 SSTR2 BDKRB1 OR52A1 EDNRB | 6.00e-15 | 692 | 64 | 21 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | ADRA1D ADRA2B ADRA2C MC4R HRH1 HRH2 TAAR5 OR56A1 SSTR2 EDNRB | 4.61e-12 | 112 | 64 | 10 | SM01381 |
| Domain | ADR_fam | 4.53e-06 | 10 | 64 | 3 | IPR002233 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.68e-05 | 45 | 64 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 1.84e-05 | 46 | 64 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 2.00e-05 | 47 | 64 | 4 | PF02931 | |
| Domain | Neur_channel | 2.00e-05 | 47 | 64 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.00e-05 | 47 | 64 | 4 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 2.00e-05 | 47 | 64 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 2.00e-05 | 47 | 64 | 4 | IPR006029 | |
| Domain | - | 2.00e-05 | 47 | 64 | 4 | 2.70.170.10 | |
| Domain | MFS | 3.42e-05 | 108 | 64 | 5 | PS50850 | |
| Domain | LAPTM4/5 | 3.46e-05 | 3 | 64 | 2 | IPR004687 | |
| Domain | Mtp | 3.46e-05 | 3 | 64 | 2 | PF03821 | |
| Domain | GABAA/Glycine_rcpt | 6.47e-05 | 23 | 64 | 3 | IPR006028 | |
| Domain | Glycine_rcpt_A | 6.90e-05 | 4 | 64 | 2 | IPR008127 | |
| Domain | MFS_dom | 9.58e-05 | 134 | 64 | 5 | IPR020846 | |
| Domain | Olfact_rcpt | 3.83e-04 | 393 | 64 | 7 | IPR000725 | |
| Domain | MFS | 2.34e-03 | 77 | 64 | 3 | IPR011701 | |
| Domain | MFS_1 | 2.34e-03 | 77 | 64 | 3 | PF07690 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GHR GABRE ADRA1D ADRA2B ADRA2C GLRA2 GLRB FPR3 MC4R GLRA3 HRH1 HRH2 TAAR5 SSTR2 BDKRB1 EDNRB | 4.50e-16 | 272 | 49 | 16 | M13380 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 1.94e-13 | 330 | 49 | 15 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 2.22e-13 | 333 | 49 | 15 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 8.81e-12 | 430 | 49 | 15 | MM15160 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 2.52e-11 | 463 | 49 | 15 | M507 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CXCR5 ADRA1D ADRA2B ADRA2C FPR3 MC4R HRH1 HRH2 SSTR2 BDKRB1 EDNRB | 2.95e-11 | 186 | 49 | 11 | MM15994 |
| Pathway | WP_GPCRS_NONODORANT | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C NPSR1 MC4R HRH1 HRH2 SSTR2 BDKRB1 EDNRB | 7.89e-11 | 266 | 49 | 12 | MM15843 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CXCR5 ADRA1D ADRA2B ADRA2C FPR3 MC4R HRH1 HRH2 SSTR2 BDKRB1 EDNRB | 1.07e-09 | 260 | 49 | 11 | M39397 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 2.59e-09 | 646 | 49 | 15 | MM14962 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 6.13e-09 | 42 | 49 | 6 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 6.13e-09 | 42 | 49 | 6 | MM14971 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR5 PROKR1 ADRA1D ADRA2B ADRA2C FPR3 NPSR1 MC4R HRH1 HRH2 TAAR5 XK SSTR2 BDKRB1 EDNRB | 8.01e-09 | 702 | 49 | 15 | M746 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.15e-08 | 197 | 49 | 9 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.15e-08 | 197 | 49 | 9 | MM14970 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.53e-08 | 31 | 49 | 5 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 9.08e-08 | 33 | 49 | 5 | M39585 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.42e-07 | 70 | 49 | 6 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 2.16e-07 | 75 | 49 | 6 | M39696 | |
| Pathway | REACTOME_ADRENOCEPTORS | 3.27e-06 | 9 | 49 | 3 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 3.27e-06 | 9 | 49 | 3 | MM15009 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 6.04e-06 | 132 | 49 | 6 | M48110 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.14e-05 | 16 | 49 | 3 | M39849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.64e-05 | 50 | 49 | 4 | M47951 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.32e-05 | 178 | 49 | 6 | M2890 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 8.34e-05 | 210 | 49 | 6 | MM15043 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 8.53e-05 | 417 | 49 | 8 | M4072 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.99e-05 | 217 | 49 | 6 | M18437 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 3.65e-04 | 389 | 49 | 7 | M14091 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.70e-04 | 289 | 49 | 6 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.27e-04 | 314 | 49 | 6 | M600 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 8.00e-04 | 211 | 49 | 5 | MM14502 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.44e-03 | 636 | 49 | 8 | M41834 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.51e-03 | 143 | 49 | 4 | MM15055 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.95e-03 | 19 | 49 | 2 | MM15107 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.95e-03 | 19 | 49 | 2 | M27362 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.12e-03 | 157 | 49 | 4 | M4904 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.38e-03 | 270 | 49 | 5 | M15514 | |
| Pathway | WP_GPCRS_OTHER | 4.11e-03 | 93 | 49 | 3 | M39629 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 5.16e-03 | 31 | 49 | 2 | M39369 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 5.83e-03 | 33 | 49 | 2 | MM15058 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.96e-03 | 335 | 49 | 5 | MM14503 | |
| Pubmed | 3.49e-09 | 200 | 64 | 8 | 18240029 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 9051263 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 21486797 | ||
| Pubmed | 4.13e-08 | 179 | 64 | 7 | 18577758 | ||
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 5.93e-08 | 5 | 64 | 3 | 21850450 | |
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 5.93e-08 | 5 | 64 | 3 | 18721822 | |
| Pubmed | 8.13e-08 | 300 | 64 | 8 | 19086053 | ||
| Pubmed | Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. | 1.18e-07 | 6 | 64 | 3 | 17636168 | |
| Pubmed | Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. | 3.31e-07 | 8 | 64 | 3 | 9139936 | |
| Pubmed | 4.14e-07 | 81 | 64 | 5 | 22723691 | ||
| Pubmed | Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. | 4.95e-07 | 9 | 64 | 3 | 21209093 | |
| Pubmed | 2.25e-06 | 50 | 64 | 4 | 31318583 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22399754 | ||
| Pubmed | Histamine H1 and H2 receptors but not H4 receptors are upregulated during bone marrow regeneration. | 3.33e-06 | 2 | 64 | 2 | 17420012 | |
| Pubmed | Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. | 3.33e-06 | 2 | 64 | 2 | 11574888 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20599923 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17312123 | ||
| Pubmed | Differential activation of dual signaling responses by human H1 and H2 histamine receptors. | 3.33e-06 | 2 | 64 | 2 | 12680587 | |
| Pubmed | Characterization of histamine projections and their potential cellular targets in the mouse retina. | 3.33e-06 | 2 | 64 | 2 | 19015005 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15820830 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24371118 | ||
| Pubmed | LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment. | 3.33e-06 | 2 | 64 | 2 | 21553234 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12429384 | ||
| Pubmed | Demonstration of histamine H1 and H2 receptors in chondrocytes of human osteoarthritic cartilage. | 3.33e-06 | 2 | 64 | 2 | 15928843 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11496371 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16888049 | ||
| Pubmed | Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels. | 3.33e-06 | 2 | 64 | 2 | 27382060 | |
| Pubmed | Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. | 3.33e-06 | 2 | 64 | 2 | 8670422 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32385805 | ||
| Pubmed | Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. | 3.33e-06 | 2 | 64 | 2 | 11898002 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20566747 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22606311 | ||
| Pubmed | Characterization of the regulatory regions of murine alpha 2C2 adrenoceptor subtype gene. | 3.33e-06 | 2 | 64 | 2 | 8762185 | |
| Pubmed | Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. | 3.33e-06 | 2 | 64 | 2 | 2842764 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28784756 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11689484 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11689483 | ||
| Pubmed | The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury. | 3.33e-06 | 2 | 64 | 2 | 16051691 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14982842 | ||
| Pubmed | Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. | 3.33e-06 | 2 | 64 | 2 | 17145090 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24200155 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25664905 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9421280 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 4.31e-06 | 130 | 64 | 5 | 19874574 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SLC6A1 TMEM161A CHPT1 LAPTM4B NPSR1 MC4R HRH1 BDKRB1 TMEM63A | 5.10e-06 | 697 | 64 | 9 | 28298427 |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16738217 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11603849 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15592690 | ||
| Pubmed | Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. | 9.99e-06 | 3 | 64 | 2 | 10385696 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12757445 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22560155 | ||
| Pubmed | Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. | 9.99e-06 | 3 | 64 | 2 | 12946937 | |
| Pubmed | Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. | 9.99e-06 | 3 | 64 | 2 | 10647009 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20203300 | ||
| Pubmed | Blastocyst H(2) receptor is the target for uterine histamine in implantation in the mouse. | 9.99e-06 | 3 | 64 | 2 | 10821762 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20613626 | ||
| Pubmed | Involvement of the histamine H1 receptor in the regulation of sympathetic nerve activity. | 9.99e-06 | 3 | 64 | 2 | 25680462 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19744502 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18326714 | ||
| Pubmed | Linkage mapping of alpha-2 adrenergic receptor genes to mouse chromosomes 2 and 5. | 9.99e-06 | 3 | 64 | 2 | 8281014 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26829592 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11181434 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 24236486 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19762454 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17215105 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 27751959 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22860191 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9415717 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 8843087 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20692245 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17261653 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19477404 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17920294 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18258331 | ||
| Pubmed | International Union of Pharmacology. XIII. Classification of histamine receptors. | 9.99e-06 | 3 | 64 | 2 | 9311023 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 37841583 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11927164 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18227221 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26427149 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11125002 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17075569 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22169095 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12764077 | ||
| Pubmed | Splice-specific roles of glycine receptor alpha3 in the hippocampus. | 9.99e-06 | 3 | 64 | 2 | 19723286 | |
| Pubmed | The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. | 2.00e-05 | 4 | 64 | 2 | 17288995 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 9384599 | ||
| Pubmed | Glycinergic input of widefield, displaced amacrine cells of the mouse retina. | 2.00e-05 | 4 | 64 | 2 | 19528249 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23772030 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 21224396 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 17627982 | ||
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 2.00e-05 | 4 | 64 | 2 | 28883437 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15953854 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 15920038 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 10224112 | ||
| Pubmed | Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. | 2.00e-05 | 4 | 64 | 2 | 12576552 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 22678907 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23677734 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 26739946 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 2.93e-05 | 95 | 64 | 4 | 16754659 | |
| Pubmed | Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. | 3.32e-05 | 5 | 64 | 2 | 15719258 | |
| Interaction | SLC22A2 interactions | 9.32e-08 | 82 | 55 | 6 | int:SLC22A2 | |
| GeneFamily | Glycine receptors | 1.64e-07 | 5 | 47 | 3 | 868 | |
| GeneFamily | Adrenoceptors | 1.37e-06 | 9 | 47 | 3 | 169 | |
| GeneFamily | Histamine receptors | 3.96e-05 | 4 | 47 | 2 | 187 | |
| GeneFamily | Solute carriers | 6.67e-05 | 395 | 47 | 7 | 752 | |
| GeneFamily | Olfactory receptors, family 4 | 3.48e-04 | 129 | 47 | 4 | 151 | |
| GeneFamily | Olfactory receptors, family 52 | 7.20e-03 | 49 | 47 | 2 | 165 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP | 6.97e-06 | 199 | 61 | 6 | M5694 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | SGPP1 GHR SLC7A8 SLC8A1 ADRA2B CHPT1 AQP11 SLC22A2 GPR137B LMBRD1 EDNRB | 4.08e-06 | 778 | 55 | 11 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.60e-05 | 314 | 55 | 7 | gudmap_kidney_adult_CortVasc_Tie2_k1_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.68e-05 | 441 | 55 | 8 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_1000 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.31e-05 | 142 | 55 | 5 | gudmap_kidney_adult_Podocyte_MafB_k2_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | SGPP1 GHR SLC7A8 SLC8A1 CHPT1 AQP11 SLC22A2 MFSD6 GPR137B EDNRB | 3.39e-05 | 799 | 55 | 10 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000 | SGPP1 GHR SLC7A8 CHPT1 AQP11 SLC22A2 MFSD6 GPR137B EDNRB TMEM63A | 5.49e-05 | 846 | 55 | 10 | gudmap_kidney_adult_CortVasc_Tie2_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | SGPP1 GHR SLC7A8 ADRA2B CHPT1 AQP11 SLC22A2 GPR137B C1QTNF3 LMBRD1 | 6.36e-05 | 861 | 55 | 10 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500 | 1.07e-04 | 424 | 55 | 7 | gudmap_kidney_adult_RenalCortexMixed_Std_500 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.21e-08 | 193 | 64 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.33e-07 | 180 | 64 | 6 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.41e-07 | 192 | 64 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-07 | 198 | 64 | 6 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-06 | 188 | 64 | 5 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | myeloid-macrophage|myeloid / Lineage and Cell class | 7.74e-06 | 189 | 64 | 5 | 7c7dc5361250d6848c4050f8ef995561a0984a44 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.94e-06 | 190 | 64 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.94e-06 | 190 | 64 | 5 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 191 | 64 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.14e-06 | 191 | 64 | 5 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 8.14e-06 | 191 | 64 | 5 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.35e-06 | 192 | 64 | 5 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 8.56e-06 | 193 | 64 | 5 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 8.78e-06 | 194 | 64 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 9.00e-06 | 195 | 64 | 5 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.23e-06 | 196 | 64 | 5 | 646a8d47dddffdfd2d8a62245ea6cd49f9510a1a | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.23e-06 | 196 | 64 | 5 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.23e-06 | 196 | 64 | 5 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.23e-06 | 196 | 64 | 5 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.23e-06 | 196 | 64 | 5 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.23e-06 | 196 | 64 | 5 | 88517bb92be2f05c1e1ad94af22ac10d8c5c13c7 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.23e-06 | 196 | 64 | 5 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.46e-06 | 197 | 64 | 5 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.46e-06 | 197 | 64 | 5 | 0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.46e-06 | 197 | 64 | 5 | a6aa5991d566c28440f7e24a30933e69669064f2 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 9.69e-06 | 198 | 64 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 46f9c28b24e39acdf0481a02b6eb86ecdd83c504 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-05 | 200 | 64 | 5 | af743dfef7e7cfaef1c494999757123f93a213e3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 154 | 64 | 4 | 66c93733116e31b65dfb4b0b00de5c39d19cdb84 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-05 | 155 | 64 | 4 | 84221a285277292f7225eb69508c887541abeed1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.70e-05 | 157 | 64 | 4 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | Control-APC-like-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 8.29e-05 | 160 | 64 | 4 | 463dd624ca5c375b6ff7c269f4ef4b9d74f4b669 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.70e-05 | 162 | 64 | 4 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 163 | 64 | 4 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 9.56e-05 | 166 | 64 | 4 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-05 | 166 | 64 | 4 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 9.78e-05 | 167 | 64 | 4 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 64 | 4 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 64 | 4 | f982f2e0d341fa27229f443ebe5c0e4a9e63bda6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 64 | 4 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | 001254db9f4c346d06d31a7fa1213498f92e4280 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | ce2bc1797707c3f48ef551de7edbfd7b47e5a36e | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | 1973fff0d7e1a94b31f461a39b91cc7984ebd8f1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 180 | 64 | 4 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.31e-04 | 180 | 64 | 4 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 182 | 64 | 4 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-04 | 183 | 64 | 4 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Nefm_(Deep_layer_pyramidal_cells--layer_5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 70 | 64 | 3 | 3fe560cd34a8f264f33dca1479950a60d10a16d9 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.45e-04 | 185 | 64 | 4 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.51e-04 | 187 | 64 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 1.54e-04 | 188 | 64 | 4 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 1.54e-04 | 188 | 64 | 4 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 1.54e-04 | 188 | 64 | 4 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.57e-04 | 189 | 64 | 4 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-04 | 190 | 64 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.61e-04 | 190 | 64 | 4 | 9db04555c98eca1df15d144fbb499e0ba06660d5 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-04 | 191 | 64 | 4 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 65083daf317f66556dc047eb19297dcbe9c70299 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 192 | 64 | 4 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 193 | 64 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 193 | 64 | 4 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 193 | 64 | 4 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | myeloid-macrophage|World / Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | b13e694123b87ed8ad1786feb996398ddd84e94b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 194 | 64 | 4 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.74e-04 | 194 | 64 | 4 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 195 | 64 | 4 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 195 | 64 | 4 | e94bac6a5c788ee160d7feaf2a3c512a3691f995 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 196 | 64 | 4 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.81e-04 | 196 | 64 | 4 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 196 | 64 | 4 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 3cf73ed99f3efa76b632c16a8b98b6b7758ff63f | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.81e-04 | 196 | 64 | 4 | bd828596c5b3fd5e4156f555e532f3de99d32f92 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 196 | 64 | 4 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 196 | 64 | 4 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 196 | 64 | 4 | 142fd80ff74979cc2f9088fc3fcbfed374afb973 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-04 | 196 | 64 | 4 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| Computational | Genes in the cancer module 146. | 6.83e-07 | 102 | 34 | 6 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | 1.07e-06 | 355 | 34 | 9 | MODULE_27 | |
| Computational | Neurotransmitter (GABA) receptor. | 1.28e-05 | 15 | 34 | 3 | MODULE_215 | |
| Computational | Membranal receptors. | 2.29e-05 | 517 | 34 | 9 | MODULE_64 | |
| Computational | Ion channels. | 8.03e-05 | 27 | 34 | 3 | MODULE_214 | |
| Computational | Genes in the cancer module 288. | 2.09e-04 | 37 | 34 | 3 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | 5.99e-04 | 124 | 34 | 4 | MODULE_289 | |
| Computational | Genes in the cancer module 396. | 6.28e-04 | 12 | 34 | 2 | MODULE_396 | |
| Computational | AcetylCholine receptors. | 8.63e-04 | 14 | 34 | 2 | MODULE_328 | |
| Computational | Genes in the cancer module 267. | 9.94e-04 | 15 | 34 | 2 | MODULE_267 | |
| Computational | Genes in the cancer module 141. | 1.13e-03 | 16 | 34 | 2 | MODULE_141 | |
| Computational | Ion channels. | 1.37e-03 | 70 | 34 | 3 | MODULE_316 | |
| Computational | Vesicular transport / synapse genes. | 2.16e-03 | 82 | 34 | 3 | MODULE_274 | |
| Computational | GPCR signaling pathways (immune and neuro). | 2.82e-03 | 90 | 34 | 3 | MODULE_375 | |
| Computational | Genes in the cancer module 367. | 3.74e-03 | 29 | 34 | 2 | MODULE_367 | |
| Computational | Caner module 265: IL receptors. | 3.74e-03 | 29 | 34 | 2 | MODULE_265 | |
| Computational | Genes in the cancer module 134. | 4.00e-03 | 30 | 34 | 2 | MODULE_134 | |
| Drug | xylometazoline | 1.97e-09 | 7 | 64 | 4 | ctd:C009695 | |
| Drug | Doxepin | 2.25e-09 | 20 | 64 | 5 | DB01142 | |
| Drug | Oxymetazoline | 3.94e-09 | 8 | 64 | 4 | ctd:D010109 | |
| Drug | iso-THAZ | 8.46e-08 | 4 | 64 | 3 | CID003047783 | |
| Drug | protostrychnine | 8.46e-08 | 4 | 64 | 3 | CID005320746 | |
| Drug | 7-nitroindoline | 8.46e-08 | 4 | 64 | 3 | CID013566747 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 8.46e-08 | 4 | 64 | 3 | CID000383689 | |
| Drug | SC-49648 | 8.46e-08 | 4 | 64 | 3 | CID000195696 | |
| Drug | akuammiline | 8.46e-08 | 4 | 64 | 3 | CID005367018 | |
| Drug | NSC381080 | 8.46e-08 | 4 | 64 | 3 | CID000165497 | |
| Drug | N-methyl-THIP | 8.46e-08 | 4 | 64 | 3 | CID000134373 | |
| Drug | SC-48981 | 8.46e-08 | 4 | 64 | 3 | CID000126573 | |
| Drug | SC-50132 | 8.46e-08 | 4 | 64 | 3 | CID000195719 | |
| Drug | SR 42641 | 8.46e-08 | 4 | 64 | 3 | CID000129049 | |
| Drug | azetidine-3-carboxylic acid | 2.11e-07 | 5 | 64 | 3 | CID000093192 | |
| Drug | Lindane | 2.11e-07 | 5 | 64 | 3 | DB00431 | |
| Drug | Cao C | 2.11e-07 | 5 | 64 | 3 | CID000166617 | |
| Drug | oxanilide | 2.11e-07 | 5 | 64 | 3 | CID000069288 | |
| Drug | iso-THAO | 2.11e-07 | 5 | 64 | 3 | CID000127199 | |
| Drug | ALX1393 | 2.11e-07 | 5 | 64 | 3 | CID016078939 | |
| Drug | pleiocarpamine | 2.11e-07 | 5 | 64 | 3 | CID000558637 | |
| Drug | mafoprazine | 2.11e-07 | 5 | 64 | 3 | CID000071241 | |
| Drug | gevotroline | 2.11e-07 | 5 | 64 | 3 | CID000060546 | |
| Drug | Methotrimeprazine | 2.13e-07 | 19 | 64 | 4 | DB01403 | |
| Drug | di-Z | 2.66e-07 | 20 | 64 | 4 | CID000656933 | |
| Drug | Xylometazoline | 4.21e-07 | 6 | 64 | 3 | DB06694 | |
| Drug | THAZ | 4.21e-07 | 6 | 64 | 3 | CID000171289 | |
| Drug | mV GABA | 4.21e-07 | 6 | 64 | 3 | CID000128435 | |
| Drug | caged glycine | 4.21e-07 | 6 | 64 | 3 | CID000192642 | |
| Drug | brometone | 4.21e-07 | 6 | 64 | 3 | CID000006424 | |
| Drug | minaxolone | 4.21e-07 | 6 | 64 | 3 | CID000071960 | |
| Drug | thiomuscimol | 4.21e-07 | 6 | 64 | 3 | CID000005448 | |
| Drug | thio-THIP | 4.21e-07 | 6 | 64 | 3 | CID000656720 | |
| Drug | AC1L90PQ | 4.21e-07 | 6 | 64 | 3 | CID000436036 | |
| Drug | urethane | 4.77e-07 | 169 | 64 | 7 | CID000005641 | |
| Drug | alpha-EMTBL | 7.35e-07 | 7 | 64 | 3 | CID000128423 | |
| Drug | CID189778 | 7.35e-07 | 7 | 64 | 3 | CID000189778 | |
| Drug | propyl methanethiosulfonate | 7.35e-07 | 7 | 64 | 3 | CID000529387 | |
| Drug | thiocolchicoside | 7.35e-07 | 7 | 64 | 3 | CID000072067 | |
| Drug | L-serinamide | 7.35e-07 | 7 | 64 | 3 | CID000101138 | |
| Drug | Boc-glycine | 7.35e-07 | 7 | 64 | 3 | CID000078288 | |
| Drug | PK 8165 | 7.35e-07 | 7 | 64 | 3 | CID000071219 | |
| Drug | Quetiapine | 8.10e-07 | 26 | 64 | 4 | DB01224 | |
| Drug | pitrazepin | 9.49e-07 | 27 | 64 | 4 | CID000146222 | |
| Drug | WT702 | 1.17e-06 | 8 | 64 | 3 | CID000089643 | |
| Drug | isostrychnine | 1.17e-06 | 8 | 64 | 3 | CID000264626 | |
| Drug | Atonik | 1.76e-06 | 9 | 64 | 3 | CID000069471 | |
| Drug | nortropanol | 1.76e-06 | 9 | 64 | 3 | CID000068147 | |
| Drug | AC1NSJX8 | 1.76e-06 | 9 | 64 | 3 | CID005311059 | |
| Drug | NSC129536 | 1.76e-06 | 9 | 64 | 3 | CID000004815 | |
| Drug | SR 57227A | 1.76e-06 | 9 | 64 | 3 | CID000131746 | |
| Drug | DCQX | 1.76e-06 | 9 | 64 | 3 | CID000001845 | |
| Drug | Norepinephrine | 2.51e-06 | 10 | 64 | 3 | DB00368 | |
| Drug | Droxidopa | 2.51e-06 | 10 | 64 | 3 | DB06262 | |
| Drug | THBA | 2.51e-06 | 10 | 64 | 3 | CID000130993 | |
| Drug | tetradotoxin | 2.97e-06 | 428 | 64 | 9 | CID000020382 | |
| Drug | epinastine | 3.13e-06 | 36 | 64 | 4 | CID000003241 | |
| Drug | pentobarbital | 3.13e-06 | 224 | 64 | 7 | CID000004737 | |
| Drug | ip 0 | 3.44e-06 | 11 | 64 | 3 | CID000006943 | |
| Drug | Cabergoline-d5 | 3.67e-06 | 83 | 64 | 5 | CID000002512 | |
| Drug | AC1L1B1W | 3.89e-06 | 84 | 64 | 5 | CID000001248 | |
| Drug | colchicoside | 4.58e-06 | 12 | 64 | 3 | CID000092763 | |
| Drug | 5 beta-alphaxalone | 5.86e-06 | 42 | 64 | 4 | CID000068930 | |
| Drug | ABPH | 7.54e-06 | 14 | 64 | 3 | CID000092377 | |
| Drug | quinoxaline-2,3-dione | 7.54e-06 | 14 | 64 | 3 | CID011469229 | |
| Drug | Risperidone | 7.54e-06 | 14 | 64 | 3 | DB00734 | |
| Drug | isoguvacine | 7.76e-06 | 45 | 64 | 4 | CID000003765 | |
| Drug | Norepinephrine | 8.59e-06 | 171 | 64 | 6 | ctd:D009638 | |
| Drug | Calcium | 9.31e-06 | 493 | 64 | 9 | ctd:D002118 | |
| Drug | ACEA-1011 | 9.41e-06 | 15 | 64 | 3 | CID000127872 | |
| Drug | milacemide | 9.41e-06 | 15 | 64 | 3 | CID000053568 | |
| Drug | LY233536 | 1.16e-05 | 16 | 64 | 3 | CID000126239 | |
| Drug | Chlorpheniramine | 1.16e-05 | 16 | 64 | 3 | ctd:D002744 | |
| Drug | 7-Cl-Thio-Kyna | 1.40e-05 | 17 | 64 | 3 | CID003035668 | |
| Drug | Diphenhydramine | 1.40e-05 | 17 | 64 | 3 | ctd:D004155 | |
| Drug | Paliperidone | 1.40e-05 | 17 | 64 | 3 | DB01267 | |
| Drug | Pergolide | 1.40e-05 | 17 | 64 | 3 | DB01186 | |
| Drug | zatosetron | 1.40e-05 | 17 | 64 | 3 | CID000060763 | |
| Drug | amphetamine | 1.48e-05 | 284 | 64 | 7 | CID000003007 | |
| Drug | Bromocriptine | 1.68e-05 | 18 | 64 | 3 | DB01200 | |
| Drug | MNQX | 1.68e-05 | 18 | 64 | 3 | CID000130818 | |
| Drug | AC1L1CMQ | 1.99e-05 | 19 | 64 | 3 | CID000001968 | |
| Drug | PNU-120596 | 1.99e-05 | 19 | 64 | 3 | CID000311434 | |
| Drug | nipecotic acid | 2.01e-05 | 57 | 64 | 4 | CID000004498 | |
| Drug | wortmannin; Up 200; 0.01uM; ssMCF7; HG-U133A | 2.09e-05 | 200 | 64 | 6 | 404_UP | |
| Drug | 2-hydroxysaclofen | 2.30e-05 | 59 | 64 | 4 | CID000001564 | |
| Drug | SR 95531 | 2.30e-05 | 59 | 64 | 4 | CID000005275 | |
| Drug | Clonidine | 2.33e-05 | 3 | 64 | 2 | DB00575 | |
| Drug | Brimonidine | 2.33e-05 | 3 | 64 | 2 | DB00484 | |
| Drug | cyanotriphenylborate | 2.33e-05 | 3 | 64 | 2 | CID000151925 | |
| Drug | 7-chloro-4-quinolinol | 2.33e-05 | 3 | 64 | 2 | CID000066593 | |
| Drug | Tizanidine | 2.33e-05 | 3 | 64 | 2 | DB00697 | |
| Drug | propanethiol | 2.33e-05 | 20 | 64 | 3 | CID000007848 | |
| Drug | ethyltrimethylammonium | 2.72e-05 | 21 | 64 | 3 | CID000033993 | |
| Drug | meproadifen | 2.72e-05 | 21 | 64 | 3 | CID000189752 | |
| Drug | R 5135 | 2.72e-05 | 21 | 64 | 3 | CID000119544 | |
| Drug | Prazosin | 2.99e-05 | 63 | 64 | 4 | ctd:D011224 | |
| Drug | Z-Gly | 3.14e-05 | 22 | 64 | 3 | CID000014349 | |
| Drug | muscimol | 3.15e-05 | 129 | 64 | 5 | CID000004266 | |
| Drug | pentylenetetrazol | 3.27e-05 | 130 | 64 | 5 | CID000005917 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.93e-06 | 115 | 57 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | Pain, Migratory | 1.18e-04 | 49 | 57 | 3 | C0751407 | |
| Disease | Suffering, Physical | 1.18e-04 | 49 | 57 | 3 | C0751408 | |
| Disease | Pain, Crushing | 1.18e-04 | 49 | 57 | 3 | C0458259 | |
| Disease | Pain, Splitting | 1.18e-04 | 49 | 57 | 3 | C0458257 | |
| Disease | Pain | 1.18e-04 | 49 | 57 | 3 | C0030193 | |
| Disease | Radiating pain | 1.18e-04 | 49 | 57 | 3 | C0234254 | |
| Disease | Pain, Burning | 1.18e-04 | 49 | 57 | 3 | C0234230 | |
| Disease | Ache | 1.18e-04 | 49 | 57 | 3 | C0234238 | |
| Disease | Withdrawal Symptoms | 1.96e-04 | 58 | 57 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.96e-04 | 58 | 57 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.96e-04 | 58 | 57 | 3 | C0038587 | |
| Disease | decanoylcarnitine measurement | 2.39e-04 | 12 | 57 | 2 | EFO_0021039 | |
| Disease | pipecolate measurement | 2.82e-04 | 13 | 57 | 2 | EFO_0021006 | |
| Disease | nervousness | 4.32e-04 | 16 | 57 | 2 | NCIT_C74532 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 6.14e-04 | 19 | 57 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Visual seizure | 9.96e-04 | 101 | 57 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 9.96e-04 | 101 | 57 | 3 | C0270846 | |
| Disease | Generalized seizures | 9.96e-04 | 101 | 57 | 3 | C0234533 | |
| Disease | Clonic Seizures | 9.96e-04 | 101 | 57 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 9.96e-04 | 101 | 57 | 3 | C0422855 | |
| Disease | Gustatory seizure | 9.96e-04 | 101 | 57 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 9.96e-04 | 101 | 57 | 3 | C0422850 | |
| Disease | Olfactory seizure | 9.96e-04 | 101 | 57 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 9.96e-04 | 101 | 57 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 9.96e-04 | 101 | 57 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 9.96e-04 | 101 | 57 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 9.96e-04 | 101 | 57 | 3 | C0751496 | |
| Disease | Jacksonian Seizure | 9.96e-04 | 101 | 57 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 9.96e-04 | 101 | 57 | 3 | C0751056 | |
| Disease | Atonic Absence Seizures | 9.96e-04 | 101 | 57 | 3 | C0751123 | |
| Disease | Complex partial seizures | 9.96e-04 | 101 | 57 | 3 | C0149958 | |
| Disease | Single Seizure | 9.96e-04 | 101 | 57 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 9.96e-04 | 101 | 57 | 3 | C4317109 | |
| Disease | Nonepileptic Seizures | 9.96e-04 | 101 | 57 | 3 | C3495874 | |
| Disease | Tonic Seizures | 1.02e-03 | 102 | 57 | 3 | C0270844 | |
| Disease | Absence Seizures | 1.02e-03 | 102 | 57 | 3 | C4316903 | |
| Disease | Convulsions | 1.02e-03 | 102 | 57 | 3 | C4048158 | |
| Disease | Seizures, Focal | 1.08e-03 | 104 | 57 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 1.08e-03 | 104 | 57 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.08e-03 | 104 | 57 | 3 | C0494475 | |
| Disease | sensory perception of smell | 1.44e-03 | 29 | 57 | 2 | GO_0007608 | |
| Disease | blood vanadium measurement | 1.54e-03 | 30 | 57 | 2 | EFO_0021533 | |
| Disease | hypertension (is_implicated_in) | 1.67e-03 | 121 | 57 | 3 | DOID:10763 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFRWVLTFFFSVFYL | 121 | Q8N814 | |
| VVAFLVCWAPYHFFA | 256 | P46663 | |
| VCWAPYHFFAFLEFL | 261 | P46663 | |
| YVLFFFNLLFWICGC | 11 | P19397 | |
| SIFFLCWSPYHIVIF | 266 | P32302 | |
| NNWFILSFCIFLPFF | 686 | Q9Y3Q7 | |
| FVLCWFPFFFSYSLY | 391 | P18825 | |
| ALWAAFLASCFFPYR | 341 | Q6IC98 | |
| VIGVFVLCWFPFFFS | 376 | P18089 | |
| VLCWFPFFFSYSLGA | 381 | P18089 | |
| WLFSFYFCLPLAITA | 276 | P24530 | |
| IPLLTWSFICYFFFQ | 241 | Q5VUY0 | |
| FPLAFLIFNIFYWVI | 436 | O75311 | |
| FPIIYLLFWAFLLVF | 426 | Q9UHI5 | |
| PDLFKFPFFEAICWF | 391 | Q6ZMT4 | |
| LAFICCWSPYFLFDI | 281 | Q6W5P4 | |
| CWSPYFLFDILDNFN | 286 | Q6W5P4 | |
| VGWLIPFFCYRLFDF | 106 | Q15012 | |
| SVILFCVFFWIPFVY | 106 | Q9NUN5 | |
| RDCLWKFFFPPDYQV | 351 | Q2LD37 | |
| VVASFFICWFPYELI | 246 | P25089 | |
| IFWFNVPEIYFDSCL | 86 | Q9UKL2 | |
| LLFFGPCVFIYAWPF | 241 | Q8NH21 | |
| VVILFFGPCIYFYIW | 246 | Q8NGD4 | |
| GAFIICWFPYFTAFV | 241 | P25021 | |
| YPWECFVFCLIIFGT | 166 | A5PLL7 | |
| WIIPFFCYQIFDFAL | 191 | Q86VI4 | |
| WVLGCTPFIALAYFF | 116 | A6NFX1 | |
| TFFFFNVLYWLVCLN | 491 | P78334 | |
| FPFCFLFFNVIYWSI | 481 | P48167 | |
| LLFFGPCVFIYAWPF | 241 | Q8NGA8 | |
| ALAAPILCLFWLYFF | 671 | O94886 | |
| YFIEFCSAPFWGVVA | 111 | Q6ZSS7 | |
| FQLWIAFPFCATYAV | 26 | Q8NGF1 | |
| LIYWQLLALFFLPFC | 6 | Q9BXJ4 | |
| CLFYWALYFNPIINI | 421 | Q9NZS9 | |
| DFANCVFPFWYRRLI | 86 | Q075Z2 | |
| QFTCEEDFYFPWLLI | 256 | P10912 | |
| PFWIGPFQAFFCIYD | 81 | Q8N118 | |
| FPLAFLIFNIFYWIT | 426 | P23416 | |
| VCWAPFFLHLIFYIS | 256 | P32245 | |
| CFCILSYLPWFEVFY | 96 | Q8TEH3 | |
| MAAFILCWIPYFIFF | 421 | P35367 | |
| LCWIPYFIFFMVIAF | 426 | P35367 | |
| LPNFFFLLYYWCIPE | 271 | O15244 | |
| IFWYDLRSISFPACF | 91 | Q8NGH5 | |
| LLFFGPCVFIYAWPF | 241 | Q96R69 | |
| ANSLSPFVFWLLYCF | 106 | O60478 | |
| PFVFWLLYCFPVCLQ | 111 | O60478 | |
| VFDIFIWFAYFNSAC | 286 | O14804 | |
| LFLVFFECVSISWFY | 461 | P30531 | |
| FFCFVWFLANLSYQE | 246 | Q8WV83 | |
| FYFQPWAQEAVCRYF | 481 | Q96GM5 | |
| LFPWFCFCFQRAFKS | 236 | Q8IYX1 | |
| VLRFFLEYQWFVDFA | 96 | Q9NX61 | |
| VWLCLLCYFAFPFQL | 116 | Q7Z3Q1 | |
| ELFYILFFPFWIWNL | 141 | Q9BX95 | |
| AETFTDIFLCWFPFY | 51 | Q9H902 | |
| DIFLCWFPFYYELKI | 56 | Q9H902 | |
| VVAVFIFCWLPFYIF | 261 | P30874 | |
| IFCWLPFYIFNVSSV | 266 | P30874 | |
| VFVLCWFPFFFVLPL | 356 | P25100 | |
| MCFDEAFPQFFIVYW | 226 | Q8NBQ7 | |
| YPDWFFFCSFIGMFV | 156 | Q8WUD6 | |
| CWAPFYGFTIVRDFF | 296 | Q8TCW9 | |
| VPFFKATCVYFVLWL | 16 | Q8N2M4 | |
| CLKLVNYSFFFWLPF | 301 | Q8NCC5 | |
| PFSEVLAYFTFCLWI | 121 | Q6UWH6 | |
| LAYFTFCLWIIPFAF | 126 | Q6UWH6 | |
| PIFWIFPYFFESRIC | 311 | Q9H5U6 | |
| SAVWYLIFFCPLDLF | 91 | Q9H6F2 | |
| ILINFFSFFLYPWIL | 241 | P51811 | |
| FACKFSEPVYAAFWL | 306 | Q309B1 | |
| LLTFFFFPICVVFAW | 236 | P32418 |